These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 20097580)

  • 1. L-arginine and antioxidant diet supplementation partially restores nitric oxide-dependent regulation of phenylephrine renal vasoconstriction in diabetics rats.
    Coronel I; Arellano-Mendoza MG; del Valle-Mondragon L; Vargas-Robles H; Castorena-Torres F; Romo E; Rios A; Escalante B
    J Ren Nutr; 2010 May; 20(3):158-68. PubMed ID: 20097580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB; Paramar AN; Balaraman R
    Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderate exercise with a dietary vitamin C and e combination protects against streptozotocin-induced oxidative damage to the kidney and lens in pregnant rats.
    Simşek M; Naziroğlu M; Erdinç A
    Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):53-9. PubMed ID: 15662597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detrimental effects of nitric oxide on mesenteric circulation during endotoxaemia and its reversal by aminoguanidine.
    Yorganci K; Sayek I; Ismailoglu UB; Sahin-Erdemli I
    Eur J Surg; 2000 Nov; 166(11):888-93. PubMed ID: 11097157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide inhibition simulates the enhancement of alpha 1 agonist-induced vasoconstriction in diabetes.
    Dresner LS; Wang SP; West MW; Ponomarenko IN; Mueller CM; Wait RB
    J Surg Res; 1997 Jul; 70(2):119-23. PubMed ID: 9245559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
    El-Mas MM; Mohy El-Din MM; El-Gowilly SM; Sharabi FM
    Eur J Pharmacol; 2004 Mar; 487(1-3):149-58. PubMed ID: 15033387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.
    Satoh M; Fujimoto S; Haruna Y; Arakawa S; Horike H; Komai N; Sasaki T; Tsujioka K; Makino H; Kashihara N
    Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1144-52. PubMed ID: 15687247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats.
    Ceylan-Isik A; Hünkar T; Aşan E; Kaymaz F; Ari N; Söylemezoğlu T; Renda N; Soncul H; Bali M; Karasu C;
    J Pharm Pharmacol; 2007 Dec; 59(12):1629-41. PubMed ID: 18053324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal vasoconstriction induced by oxidized LDL is inhibited by scavengers of reactive oxygen species and L-arginine.
    Rahman MM; Varghese Z; Fuller BJ; Moorhead JF
    Clin Nephrol; 1999 Feb; 51(2):98-107. PubMed ID: 10069645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms.
    Roghani M; Baluchnejadmojarad T
    Vascul Pharmacol; 2009; 51(2-3):84-9. PubMed ID: 19393342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pioglitazone on L-NAME induced hypertension in diabetic rats.
    Majithiya JB; Parmar AN; Trivedi CJ; Balaraman R
    Vascul Pharmacol; 2005 Oct; 43(4):260-6. PubMed ID: 16168716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary docosahexaenoic acid on the endothelium-dependent vasorelaxation in diabetic rats.
    Goirand F; Ovide-Bordeaux S; Renaud JF; Grynberg A; Lacour B
    Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):184-90. PubMed ID: 15743401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxatory effect of magnesium on mesenteric vascular beds differs from normal and streptozotocin induced diabetic rats.
    Soltani N; Keshavarz M; Sohanaki H; Zahedi Asl S; Dehpour AR
    Eur J Pharmacol; 2005 Jan; 508(1-3):177-81. PubMed ID: 15680269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
    Dewhurst M; Omawari N; Tomlinson DR
    Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beneficial in vitro effects of lovastatin and chelerythrine on relaxatory response to acetylcholine in the perfused mesentric bed isolated from diabetic rats.
    Fatehi-Hassanabad Z; Imen-Shahidi M; Fatehi M; Farrokhfall K; Parsaeei H
    Eur J Pharmacol; 2006 Mar; 535(1-3):228-33. PubMed ID: 16516190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aminoguanidine and N(omega)-nitro-L-arginine methyl ester on vascular hyporeactivity induced by endotoxaemia.
    Ismailoglu UB; Pekiner C; Yorganci K; Sahin-Erdemli I
    Eur J Surg; 2001 Nov; 167(11):803-9. PubMed ID: 11848232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of nitric oxide in the modulation of the vascular response to angiotensin II in hypertensive rats].
    Sánchez Mendoza A; Vázquez Cruz B; Escalante Acosta BA
    Arch Inst Cardiol Mex; 1996; 66(4):306-12. PubMed ID: 8984951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat.
    Chen YJ; Li J; Quilley J
    Eur J Pharmacol; 2006 Jul; 541(1-2):80-6. PubMed ID: 16753143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endothelium-derived relaxing factors in the renal response to vasoactive agents in hypothyroid rats.
    Moreno JM; Wangensteen R; Sainz J; Rodríguez-Gomez I; Chamorro V; Osuna A; Vargas F
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E182-8. PubMed ID: 12657567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.